• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment.

作者信息

Barton Matthias, Meyer Matthias R

机构信息

University of Zürich, Zürich, Switzerland.

Andreas Grüntzig Foundation, Zürich, Switzerland.

出版信息

JACC Basic Transl Sci. 2020 Mar 23;5(3):296-299. doi: 10.1016/j.jacbts.2020.02.001. eCollection 2020 Mar.

DOI:10.1016/j.jacbts.2020.02.001
PMID:32215378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7091503/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c21/7091503/213fe18d546a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c21/7091503/213fe18d546a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c21/7091503/213fe18d546a/fx1.jpg

相似文献

1
Heart Failure With Preserved Ejection Fraction in Women: New Clues to Causes and Treatment.女性射血分数保留的心力衰竭：病因与治疗的新线索
JACC Basic Transl Sci. 2020 Mar 23;5(3):296-299. doi: 10.1016/j.jacbts.2020.02.001. eCollection 2020 Mar.
2
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式：合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
3
Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis.磷酸二酯酶-5抑制剂改善左心室射血分数降低的心力衰竭患者的临床结局、运动能力和肺血流动力学：一项荟萃分析。
J Clin Med Res. 2017 Jun;9(6):488-498. doi: 10.14740/jocmr3008w. Epub 2017 Apr 26.
4
Left ventricular diastolic and systolic dyssynchrony and dysfunction in heart failure with preserved ejection fraction and a narrow QRS complex.左心室舒张和收缩不同步以及射血分数保留的心力衰竭和 QRS 波群狭窄的功能障碍。
Int J Med Sci. 2018 Jan 1;15(2):108-114. doi: 10.7150/ijms.21956. eCollection 2018.
5
Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.磷酸二酯酶 5 抑制剂西地那非在射血分数保留型心力衰竭合并前、后毛细血管性肺动脉高压患者中的应用：一项随机、开放标签的初步研究。
BMC Cardiovasc Disord. 2020 Sep 10;20(1):408. doi: 10.1186/s12872-020-01671-2.
6
Distinct features of calcium handling and β-adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction.在射血分数保留型心力衰竭与射血分数降低型心力衰竭中，钙处理和β肾上腺素能敏感性的不同特征。
J Physiol. 2020 Nov;598(22):5091-5108. doi: 10.1113/JP280425. Epub 2020 Sep 9.
7
[Clinical characteristics of heart failure with recovered ejection fraction].射血分数恢复的心力衰竭的临床特征
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Apr 24;49(4):333-339. doi: 10.3760/cma.j.cn112148-20200713-00554.
8
Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.射血分数保留的心力衰竭患者右心室-肺动脉耦联受损及西地那非的作用：舒张性心力衰竭磷酸二酯酶-5抑制改善临床状态和运动能力（RELAX）试验的一项辅助分析
Circ Heart Fail. 2016 Apr;9(4):e002729. doi: 10.1161/CIRCHEARTFAILURE.115.002729.
9
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.舒张性心力衰竭射血分数保留中心肌细胞钙稳态的病因依赖性损伤。
J Am Coll Cardiol. 2021 Feb 2;77(4):405-419. doi: 10.1016/j.jacc.2020.11.044.
10
Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study.心力衰竭射血分数保留与降低患者的生物标志物谱：DIAST-CHF 研究结果。
ESC Heart Fail. 2023 Feb;10(1):200-210. doi: 10.1002/ehf2.14167. Epub 2022 Oct 2.

引用本文的文献

1
Underpinnings of heart failure with preserved ejection fraction in women - From prevention to improving function. A co-publication with the American Journal of Preventive Cardiology and the Journal of Cardiac Failure.女性射血分数保留的心力衰竭的基础——从预防到改善功能。与《美国预防心脏病学杂志》和《心力衰竭杂志》合作出版。
Am J Prev Cardiol. 2025 Feb 19;23:100928. doi: 10.1016/j.ajpc.2025.100928. eCollection 2025 Sep.
2
The G protein-coupled oestrogen receptor GPER in health and disease: an update.G 蛋白偶联雌激素受体 GPER 在健康和疾病中的作用：最新进展。
Nat Rev Endocrinol. 2023 Jul;19(7):407-424. doi: 10.1038/s41574-023-00822-7. Epub 2023 May 16.
3

本文引用的文献

1
Heart Failure with Preserved Ejection Fraction and Obesity: Syndrome of cGMP-PKG Deficiency in Post-Menopausal Women.射血分数保留的心力衰竭与肥胖：绝经后女性的cGMP-PKG缺乏综合征
JACC Case Rep. 2020 Jan;2(1):28-32. doi: 10.1016/j.jaccas.2019.11.065. Epub 2020 Jan 15.
2
Estrogen Receptor-α Non-Nuclear Signaling Confers Cardioprotection and Is Essential to cGMP-PDE5 Inhibition Efficacy.雌激素受体-α非核信号传导赋予心脏保护作用，且对环磷酸鸟苷磷酸二酯酶5（cGMP-PDE5）抑制功效至关重要。
JACC Basic Transl Sci. 2020 Mar 4;5(3):282-295. doi: 10.1016/j.jacbts.2019.12.009. eCollection 2020 Mar.
3
Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
G Protein-Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications.
G 蛋白偶联雌激素受体 GPER：分子药理学和治疗应用。
Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:295-320. doi: 10.1146/annurev-pharmtox-031122-121944.
4
Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的性别差异及相关的雌激素效应。
Heart Fail Rev. 2023 Jul;28(4):937-948. doi: 10.1007/s10741-022-10274-2. Epub 2022 Oct 3.
5
Proteogenomics reveals sex-biased aging genes and coordinated splicing in cardiac aging.蛋白质基因组学揭示了心脏衰老过程中的性别偏向性衰老基因和协调剪接。
Am J Physiol Heart Circ Physiol. 2022 Sep 1;323(3):H538-H558. doi: 10.1152/ajpheart.00244.2022. Epub 2022 Aug 5.
6
Heart Failure Subtypes and Cardiomyopathies in Women.女性心力衰竭亚型和心肌病。
Circ Res. 2022 Feb 18;130(4):436-454. doi: 10.1161/CIRCRESAHA.121.319900. Epub 2022 Feb 17.
7
Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women: Intra- and Extra-Cardiomyocyte Maladaptive Alterations Scaffolded by Estrogen Deficiency.绝经后女性射血分数保留的心力衰竭的优势：由雌激素缺乏构建的心肌细胞内和细胞外适应性不良改变。
Front Cell Dev Biol. 2021 Sep 29;9:685996. doi: 10.3389/fcell.2021.685996. eCollection 2021.
8
Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.雌雄小鼠血管和心脏衰老时程及机制的性别差异：平滑肌细胞盐皮质激素受体的作用。
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H169-H180. doi: 10.1152/ajpheart.00262.2020. Epub 2020 Oct 23.
9
On the search for the right definition of heart failure with preserved ejection fraction.探寻射血分数保留的心力衰竭的恰当定义。
Cardiol J. 2020;27(5):449-468. doi: 10.5603/CJ.a2020.0124. Epub 2020 Sep 28.
绝经相关雌激素减少与 HFpEF 的发病机制：JACC 每周综述专题。
J Am Coll Cardiol. 2020 Mar 10;75(9):1074-1082. doi: 10.1016/j.jacc.2019.12.049.
4
Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.沙库巴曲缬沙坦与缬沙坦对射血分数保留心力衰竭女性与男性患者的影响：PARAGON-HF 研究的见解。
Circulation. 2020 Feb 4;141(5):338-351. doi: 10.1161/CIRCULATIONAHA.119.044491. Epub 2019 Nov 17.
5
Physiological activation and deactivation of soluble guanylate cyclase.可溶性鸟苷酸环化酶的生理激活和失活。
Nitric Oxide. 2018 Jul 1;77:65-74. doi: 10.1016/j.niox.2018.04.011. Epub 2018 Apr 25.
6
Estrogens and Coronary Artery Disease: New Clinical Perspectives.雌激素与冠状动脉疾病：新的临床视角
Adv Pharmacol. 2016;77:307-60. doi: 10.1016/bs.apha.2016.05.003. Epub 2016 Jun 29.
7
The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.心血管系统中雌激素受体信号传导日益增加的复杂性
Circ Res. 2016 Mar 18;118(6):994-1007. doi: 10.1161/CIRCRESAHA.115.305376. Epub 2016 Jan 7.
8
Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy.雌激素疗法对压力超负荷诱导的心力衰竭的挽救作用。
J Am Heart Assoc. 2016 Jan 22;5(1):e002482. doi: 10.1161/JAHA.115.002482.
9
PDE5 inhibitor efficacy is estrogen dependent in female heart disease.PDE5 抑制剂的疗效在女性心脏病中依赖于雌激素。
J Clin Invest. 2014 Jun;124(6):2464-71. doi: 10.1172/JCI70731. Epub 2014 May 16.
10
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.磷酸二酯酶-5 抑制剂对射血分数保留心力衰竭患者运动能力和临床状态的影响：一项随机临床试验。
JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.